NCT02351960View on ClinicalTrials.gov

Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

296

Participants

Timeline

Start Date

March 19, 2015

Primary Completion Date

June 22, 2016

Study Completion Date

July 13, 2016

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

Dexlansoprazole

Dexlansoprazole capsules

Trial Locations (10)

Unknown

Shatin

Gyeonggi-do

Seoul

Kaoshiung

Taichung

Tainan City

Taipei

Taoyuan District

463-707

Gyeonggi-do

137-701

Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY